Mnemo Therapeutics
Mnemo Therapeutics specializes in biotechnology and life science.
Operating in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), Mnemo Therapeutics was founded in 2019.
Mnemo Therapeutics is positioned in biotechnology, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Series_A.
Recorded headcount: c_00051_00100 employees.
Public records show total funding of about $75M.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | FR |
| Founded | 2019 |
| Employees | c_00051_00100 |
| Stage | series_a |
| Total funding | $75,000,000 |
Website: www.mnemo-tx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account